Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Keita Masuzawa, M.D., Ph.D.

Concepts (119)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Foramen Ovale, Patent120162100.430 Why?
Lung Neoplasms132022135860.380 Why?
Aniline Compounds4202010940.360 Why?
Carcinoma, Non-Small-Cell Lung9202054320.360 Why?
Acrylamides420202610.350 Why?
Fibroblast Growth Factor 912021130.190 Why?
Lung Diseases, Interstitial220229400.190 Why?
Protein Kinase Inhibitors4202057040.160 Why?
GTPase-Activating Proteins120224670.160 Why?
Drug Resistance, Neoplasm5202053410.160 Why?
Guanine Nucleotide Exchange Factors120225720.150 Why?
Genes, erbB-1120191630.150 Why?
Insulin-Like Growth Factor II120202710.150 Why?
Signal Recognition Particle12018450.150 Why?
Receptors, Antigen, T-Cell, gamma-delta120203540.150 Why?
Japan4202414180.150 Why?
Receptor, IGF Type 1120203840.140 Why?
Neoplasms, Multiple Primary120215940.140 Why?
Dyspnea3202413520.140 Why?
Small Cell Lung Carcinoma120214540.130 Why?
Pyrrolidines120183410.130 Why?
Septal Occluder Device120161260.120 Why?
Pneumonia2202221630.110 Why?
Muscular Diseases120185530.110 Why?
Genome-Wide Association Study22022127950.100 Why?
Proto-Oncogene Proteins p21(ras)1202017670.100 Why?
Mutation52020302370.100 Why?
Reactive Oxygen Species1202021520.100 Why?
Pyrazines1201812050.100 Why?
Idiopathic Pulmonary Fibrosis120175220.100 Why?
Piperazines2202025540.090 Why?
Xenograft Model Antitumor Assays4202036120.090 Why?
Sulfonamides1202019820.090 Why?
Mice, Inbred BALB C4202162310.090 Why?
Intracellular Signaling Peptides and Proteins1202028920.090 Why?
Antineoplastic Agents42020136770.080 Why?
Indoles1201718360.080 Why?
Piperidines1201816670.080 Why?
Carcinoma, Hepatocellular1202123340.080 Why?
Arthritis, Rheumatoid1202237810.070 Why?
Mice, Inbred NOD2202118370.070 Why?
Cell Line, Tumor52020171420.060 Why?
Mice, SCID2202126270.060 Why?
Liver Neoplasms1202143630.060 Why?
Drug Synergism2201917600.060 Why?
Antineoplastic Combined Chemotherapy Protocols32021118780.050 Why?
Mesocricetus120222560.050 Why?
Prednisolone120223260.050 Why?
Humans2120247681710.050 Why?
Aged, 80 and over42022596260.040 Why?
Cell Transdifferentiation120211860.040 Why?
Cough120245980.040 Why?
Intracellular Space120201990.040 Why?
Lectins, C-Type120225940.040 Why?
Alleles2202268940.040 Why?
Interferon Type I120225690.040 Why?
Carboplatin120217970.040 Why?
Sequence Homology120181970.040 Why?
Female1020243971870.040 Why?
Quality of Life32024134900.030 Why?
Cluster Analysis1202427320.030 Why?
Fatigue1202415570.030 Why?
Pyrimidines2202030480.030 Why?
Multicenter Studies as Topic1202117370.030 Why?
Receptors, Immunologic1202214180.030 Why?
Molecular Dynamics Simulation120194270.030 Why?
Mice52021820490.030 Why?
Receptor Protein-Tyrosine Kinases1202216280.030 Why?
Oncogenes1202012340.030 Why?
Oxidation-Reduction1202022270.030 Why?
Protein Multimerization120199660.030 Why?
Quantitative Trait Loci1202221310.030 Why?
Gene Silencing1202015050.030 Why?
Animals620221692850.030 Why?
Paclitaxel1202117330.030 Why?
Prospective Studies32024549240.030 Why?
Immunoglobulins, Intravenous120186670.030 Why?
Apoptosis2202095270.030 Why?
Lung22022101010.030 Why?
Viral Load1202233960.030 Why?
Fatal Outcome1201718360.030 Why?
Exons1201823940.030 Why?
Disease Progression22021136680.030 Why?
Oncogene Proteins, Fusion1202016130.030 Why?
Random Allocation1201723950.030 Why?
Disease Models, Animal22022183490.020 Why?
Gene Amplification1201710950.020 Why?
Up-Regulation1202141490.020 Why?
Epithelial-Mesenchymal Transition120177570.020 Why?
Pyrazoles1202220280.020 Why?
Membrane Glycoproteins1202237130.020 Why?
RNA, Small Interfering1202034280.020 Why?
Weight Loss1202227210.020 Why?
Aged520241715020.020 Why?
Tumor Cells, Cultured1201861240.020 Why?
Protein Conformation1201839560.020 Why?
Protein-Tyrosine Kinases1201924330.020 Why?
Drug Therapy, Combination1201963160.020 Why?
Pyridines1202028940.020 Why?
Phosphorylation1202083160.020 Why?
Dose-Response Relationship, Drug12020107630.020 Why?
Glucocorticoids1201721670.020 Why?
Macrophages1202258020.020 Why?
Middle Aged420232234870.020 Why?
Amino Acid Sequence12018134220.020 Why?
Immunosuppressive Agents1201842060.020 Why?
Adult320242236460.010 Why?
Inflammation12022108730.010 Why?
Polymorphism, Single Nucleotide12022160440.010 Why?
Cell Proliferation12018104780.010 Why?
Adenocarcinoma1201963950.010 Why?
Male420213647310.010 Why?
Genetic Predisposition to Disease12022180650.010 Why?
Cohort Studies12021417530.010 Why?
Signal Transduction12020236480.010 Why?
Adolescent12024891690.010 Why?
Tomography, X-Ray Computed12017207620.010 Why?
Treatment Outcome12019653790.010 Why?
Magnetic Resonance Imaging12018367410.010 Why?
Masuzawa's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (119)
Explore
_
Co-Authors (1)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.